Celularity regains compliance with Nasdaq financial reporting requirement
CELU•Celularity regained compliance with Nasdaq’s periodic reporting requirement on Oct. 22, 2026, after filing its quarterly report on Oct. 20, closing its last of three previously disclosed deficiency matters.
1. Reporting compliance restored
Nasdaq’s determination followed Celularity’s Oct. 20 filing of its Form 10-Q for the quarter ended June 30, 2026. Nasdaq had closed the company’s minimum bid price and minimum market value deficiencies on Sept. 11; management has begun overhauling the finance organization to address recurring reporting delays.
